Table 2.
UBE2O Immunohistochemical staining of prostate cancer and adjacent non-neoplastic tissues for radical prostatectomy due to prostate cancer.
| UBE2O | Adjacent Non-Neoplastic Tissues | Prostate Cancer | Total | p Value |
|---|---|---|---|---|
| 0 | 22 | 0 | 22 | <0.001 |
| 1 | 15 | 120 | 135 | |
| 2 | 23 | 154 | 177 | |
| 3 | 1 | 81 | 82 | |
| Total | 61 | 355 | 416 |
UBE2O grade—0: negative 1: weak 2: moderate 3: strong. The number of UBE2O immunohistochemical staining of prostate cancer could be evaluated in 416 from patients including 355 prostate cancer tissues and 61 adjacent non-neoplastic tissues around prostate cancer in 382 patients with prostate cancer. 382 patients included 202 patients with prostate cancer of our hospital and 180 from purchased TMA. Adjacent non-neoplastic tissues were 39 from TMA of our hospital, 22 from purchased TMA.